Scantox is one of Europe's leading preclinical GLP-accredited CROs. From our four business units we cover a vast portfolio of services within the drug development process: Discovery (incl. neuropharmacology), Genetic Toxicology, Regulatory Toxicology and Pharmaceutical Dev & Analytical.
Scantox is headquartered in Denmark, with subsidiaries in Sweden, Denmark, UK and Austria.
In vivo services include: Exploratory toxicology; Pharmacokinetics; Efficacy models; Local tolerance studies; General toxicology; Juvenile studies; Genotox; Embryofetal studies; Medical devices; Histopathology incl. scanning; Clinical pathology incl. biomarkers; Bioanalysis; Imaging; Safety Pharmacology; Wound healing.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Copyright © American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT
to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe